Hbk Investments L P Activity Analysis: Q2 2026 Portfolio Changes
Insights into holdings changes by Hbk Investments L P during Q2 2026, focusing on significant purchases and sales.
As of June 30th, 2026, Hbk Investments L P, a substantial investor in the market, has reported notable changes to its portfolio holdings during this quarter. The detailed filing provides visibility into specific stock acquisitions and disposals.
The most significant purchase activity observed by Hbk Investments L P appears concentrated within the Healthcare sector. This includes acquiring large positions or increasing existing stakes in companies like BIO-TECHNE CORP (TECH), which saw its share count increase by 6825000, representing a portfolio allocation percentage of 5.64%. Similarly, APOGEE THERAPEUTICS INC (APGE) experienced a complete share replacement with an increase of 2850000 shares, boosting its allocation to 4.43%. The investor also significantly boosted NUVALENT INC (NUVL)'s position in the portfolio through an increase of 3483100 shares, now accounting for 5.04%. Furthermore, a major addition was made to APOGEE THERAPEUTICS INC (APGE), which replaced its entire prior position with the current one.
Additionally, in the Industrials sector, CHART INDS INC (GTLS) saw a substantial increase of 1100000 shares from its prior period position. This resulted in an allocation percentage rise to 4.38%. The investor also maintained and increased their stake in TOPBUILD COR (BLD) by adding another 2625000 shares, resulting in a complete replacement of the prior position at 10.89% allocation.
In contrast to these significant buys, Hbk Investments L P also divested substantial portions or entire positions during Q2 2026. The most prominent sale was observed in Utilities stocks, specifically TXNM ENERGY INC (TXNM). This position was completely liquidated with a decrease of -2556000 shares, leading to an 84.05% reduction and now holding just 0.32% of the portfolio.
Elsewhere in Utilities, AES CORP (AES) experienced a complete replacement scenario but with an increase rather than a decrease. However, looking at other sectors, notable exits include the sale of TRIPADVISOR INC (TRIP), which saw its share count drop by -1011888 shares and allocation percentage fall to 0.24%. The investor also disposed of the entire position in CATALYST PHARMACEUTICALS INC (CPRX), reducing its stake from a prior period allocation percentage not disclosed to just 1.04% now.
Furthermore, the investor exited positions in other companies like DDOG, TTEK, and MSTR. While the exact prior allocations for these sold positions are not provided in the changed_holdings list, their removal from the portfolio is evident based on the filing structure.